Back to Trades
NG CAROLYN
DirectorCIK 0001777346
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
NG CAROLYN, Director, has filed 1 SEC report (2026), all concentrated in Odyssey Therapeutics, Inc. (ODTX), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.